Drug-induced Pulmonary Hypertension Symposium: Applying Lessons Learned from The Aminorex Epidemic

Thursday, April 13, 2023, 7:00 AM - Friday, April 14, 2023, 1:30 PM, Hoover Institution - David & Joan Traitel Building, Stanford, CA

Pulmonary hypertension (PH) is a rare and fatal cardiopulmonary disease that disproportionately impacts women. Despite the progress in the diagnosis, clinical care, and treatment of PH, unique etiological factors are still being discovered. Iatrogenic forms of PH are one of the leading but under-appreciated causes of the disease in the modern era. This symposium will provide expertise from the following: Stanford University, international academic centers as well as the broader academic communities, including global organizations (World Health Organization, United States Food and Drug Administration, European Medicines Agency), and stakeholders (patients, industry partners, etc.) to develop a deeper understanding of “drug-induced pulmonary hypertension” and establish pharmacovigilance protocols for monitoring drug safety and rapid identification of PH in at-risk populations.

There are two ways to attend this hybrid activity: in-person or virtually.

1. In-Person
Registration Fees (Includes course materials, breakfast, lunch, a reception, and a certificate of participation).

Physician/AHP/RN - $399
Pulmonary Vascular Research Institute (PVRI) member from  low income countries - $299 (this registration type will be authenticated through PVRI)
Government Employee - $299
Student - $199
Industry (non-sponsor) - $1,500
Stanford Affiliate (Faculty, Staff, Students, Alumni) - $49

2. Virtually
Registration Fees (Join virtually, via Zoom. Fees include course material and a certificate of participation. You will receive your Zoom link the week of the symposium).

Physician/AHP/RN - $399
Pulmonary Vascular Research Institute (PVRI) member from low income countries - $299 (this registration type will be authenticated through PVRI)
Government Employee - $299
Student - $199
Industry (non-sponsor) - $1,500
Stanford Affiliate (Faculty, Staff, Students, Alumni) - $49


Tuition may be paid by Visa or MasterCard. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator. 

AMA PRA Category 1 Credits™ (12.25 hours), Non-Physician Participation Credit (12.25 hours)

1. Consider the various forms of pulmonary hypertension, based on the classifications of the World Health Organization.
2. Develop skills/strategies to identify at risk patients for pulmonary hypertension.
3. Identify drug classes and types linked to pulmonary arterial hypertension.
4. Understand drug-associated mechanisms of toxicity linked to the development of pulmonary arterial hypertension.
5. Learn pharmacovigilance methods and strategies that can help uncover existing and future pulmonary vascular related drug toxicity.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 12.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Melissa Schwartz
     Title: Events Project Manager
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

You are not logged in.

Please click the button below to login or create a new account before continuing.

Stanford Center for Continuing Medical Education (SCCME) is committed to providing a safe and healthy environment for event attendees and staff members.  SCCME’s decisions and preventive measures will be guided by the requirements and recommendations of Stanford, as well as any federal, state, and local health authorities.  We will continue to monitor the evolving situation and guidelines. 

The responsibility of a safe and healthy environment is shared among SCCME, the venue, and all event attendees.  All attendees are expected to adhere to and abide by the safety measures below, to protect against the spread of COVID-19.

Stanford strongly recommends masking indoors and in crowded outdoor settings.  

Conference Location
Stanford University
Hoover Institution
David & Joan Traitel Building
434 Lasuen Mall
Stanford, CA 94305

Nearby Hotels
View hotel options by visiting: visit.stanford.edu/basics/lodging 

Visiting Stanford
To learn more about traveling to Stanford University, please browse visit.stanford.edu.

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

This CME activity is supported in part by educational grants from Actelion Pharmaceuticals US, Inc., Merck & Co., Inc., & United Therapeutics.

DIPH Stanford Exhibit + Sponsorship Prospectus.pdf

Please review the agreement below, with registration you are agreeing to Stanford's terms and conditions. 
Stanford Medicine Post Graduate Medical Education Sponsorship & Exhibit Agreement.pdf

Exhibit at this Event

Special thank you to our sponsors and exhibitors: Actelion Pharmaceuticals US, Inc., Aerami Therapeutics, Aerovate Therapeutics, Bayer HealthCare Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Cardiovascular Medical Research and Education Fund (CMREF), CVS Health, Enzyvant Therapeutics, Inc., FLUIDDA Inc., Gossamer Bio Inc., Liquidia, Polarean, Inc., Pulmonary Vascular Research Institute (PVRI), Respira Therapeutics, Reviva Pharmaceuticals, United Therapeutics, & VIVUS.